| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Payments for purchases of treasury stock | 295,500 | 242,100 |
| Net cash used in financing activities | -286,500 | -234,000 |
| Effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents | -16,900 | -18,000 |
| Cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect | -91,600 | -118,100 |
| Cash and cash equivalents at beginning of period | 489,800 | - |
| Cash and cash equivalents at end of period | 398,200 | - |
BIO-RAD LABORATORIES, INC. (BIO)
BIO-RAD LABORATORIES, INC. (BIO)